Skip to main content

Table 7 Associations between microRNA-144-3p expression and clinicopathological features in lung adenocarcinoma, based on quantitative real-time PCR data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological feature   n mean ± SD p-value
Tissue Adjacent non-cancerous tissue 101 4.693 ± 2.607 < 0.001*
LUAD 101 2.792 ± 1.308
Age (years) < 60 41 2.8032 ± 1.31708 0.942
≥60 60 2.7838 ± 1.31347
Gender Female 45 2.9789 ± 1.46340 0.211
Male 56 2.6413 ± 1.16082
Tumor size (cm) ≤3 53 2.9115 ± 1.41270 0.332
> 3 48 2.6594 ± 1.18327
Smoke No 26 3.5146 ± 1.56261 0.027*
Yes 18 2.5722 ± 1.16539
Lymph node metastasis No 45 3.0982 ± 1.3707 0.037*
Yes 56 2.5454 ± 1.21274
Vascular invasion No 70 3.1109 ± 1.30906 < 0.001*
Yes 31 2.0710 ± 0.99515
TNM I-II 44 2.9577 ± 1.35229 0.269
III-IV 57 2.6635 ± 1.27056
  1. SD Standard deviation, LUAD Lung adenocarcinoma
  2. *p < 0.05 was considered statistically significant